Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Become a partner
ALILAROTINIB
Rx
Cancer & Blood Disorders

ALILAROTINIB

Larotrectinib
Generic (INN)
Larotrectinib
Strength
100mg
Packaging
30 capsules/bottle
Indication
Targeted treatment for cancers with an NTRK gene fusion. (See package insert.)
Registration No.
11 L 1228/24
Package Insert
English & Lao (PDF)

More in Cancer & Blood Disorders

View all →
ALIREVMENI 25mg
ALIREVMENI 25mg
Revumenib citrate
ALIMOLOTINI 150mg
ALIMOLOTINI 150mg
Mobocertinib?
MITOSIS
MITOSIS
Mitotane
ALIQUZATINI 26.5mg
Quizartinib
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文